Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension
Public ClinicalTrials.gov record NCT00847626. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-Blind, Randomized, Factorial, Efficacy and Safety Study of TAK 491 Plus Chlorthalidone Fixed-Dose Combination in Participants With Moderate to Severe Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy and safety of azilsartan medoxomil combined with chlorthalidone, once daily (QD), in participants with moderate to severe hypertension.
Study identification
- NCT ID
- NCT00847626
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,711 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- Apr 30, 2010
- Completion
- Jun 30, 2010
- Last update posted
- Feb 6, 2012
2009 – 2010
United States locations
- U.S. sites
- 84
- U.S. states
- 29
- U.S. cities
- 84
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Columbiana | Alabama | — | — |
| Not listed | Tuscaloosa | Alabama | — | — |
| Not listed | Chandler | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Scottsdale | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Buena Park | California | — | — |
| Not listed | Carmichael | California | — | — |
| Not listed | Costa Mesa | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | Palm Springs | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Vista | California | — | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | Middletown | Delaware | — | — |
| Not listed | Bradenton | Florida | — | — |
| Not listed | Deerfield Beach | Florida | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | Hallandale | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Longwood | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | Ormond Beach | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Buffalo Grove | Illinois | — | — |
| Not listed | Libertyville | Illinois | — | — |
| Not listed | Melrose Park | Illinois | — | — |
| Not listed | Fishers | Indiana | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Erlanger | Kentucky | — | — |
| Not listed | Madisonville | Kentucky | — | — |
| Not listed | Paducah | Kentucky | — | — |
| Not listed | Rockville | Maryland | — | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | Chesterfield | Michigan | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Henderson | Nevada | — | — |
| Not listed | Brick | New Jersey | — | — |
| Not listed | Margate City | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Endwell | New York | — | — |
| Not listed | Cary | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Lyndhurst | Ohio | — | — |
| Not listed | Willoughby Hills | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Ashland | Oregon | — | — |
| Not listed | Altoona | Pennsylvania | — | — |
| Not listed | Bensalem | Pennsylvania | — | — |
| Not listed | Feasterville | Pennsylvania | — | — |
| Not listed | Jenkintown | Pennsylvania | — | — |
| Not listed | Sellersville | Pennsylvania | — | — |
| Not listed | Warminster | Pennsylvania | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Florence | South Carolina | — | — |
| Not listed | Murrells Inlet | South Carolina | — | — |
| Not listed | Simpsonville | South Carolina | — | — |
| Not listed | Spartanburg | South Carolina | — | — |
| Not listed | Clarksville | Tennessee | — | — |
| Not listed | New Tazewell | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Bellaire | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | McKinney | Texas | — | — |
| Not listed | Richardson | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Magna | Utah | — | — |
| Not listed | West Jordan | Utah | — | — |
| Not listed | Arlington | Virginia | — | — |
| Not listed | Virginia Beach | Virginia | — | — |
| Not listed | Oregon | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00847626, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2012 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00847626 live on ClinicalTrials.gov.